Advancing Newborn Screening for Hemoglobinopathies: The Role of Capillary Electrophoresis

Newborn screening programs play a critical role in identifying serious diseases at an early stage, enabling timely intervention and significantly reducing morbidity and mortality in children under five years of age.

As the global prevalence of hemoglobinopathies continues to rise, screening for disorders such as sickle cell disease and thalassemias is becoming an essential component of national newborn screening programs worldwide. Accurate and reliable laboratory methods are therefore crucial to ensure effective detection and patient management from the earliest stages of life. Recognized for its high analytical performance, capillary electrophoresis provides a clear separation of hemoglobin variants and an easy detection of thalassemias.

Join us for this scientific webinar to explore the role of capillary electrophoresis in newborn screening for hemoglobinopathies, and how this method contributes to delivering efficient results in routine laboratory practice and improves outcomes for newborns worldwide.

Sebia EMEA Export team